EA201170640A1 - Дизамещенные фталазины-антагонисты сигнального пути hedgehog - Google Patents

Дизамещенные фталазины-антагонисты сигнального пути hedgehog

Info

Publication number
EA201170640A1
EA201170640A1 EA201170640A EA201170640A EA201170640A1 EA 201170640 A1 EA201170640 A1 EA 201170640A1 EA 201170640 A EA201170640 A EA 201170640A EA 201170640 A EA201170640 A EA 201170640A EA 201170640 A1 EA201170640 A1 EA 201170640A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antagonists
phthalasins
designed
signal path
hedgehog signal
Prior art date
Application number
EA201170640A
Other languages
English (en)
Other versions
EA018931B1 (ru
Inventor
Джоли Энн Бастиан
Филип Артур Хипскинд
Дэниел Джон Сэлл
Такако Уилсон
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41566219&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201170640(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA201170640A1 publication Critical patent/EA201170640A1/ru
Publication of EA018931B1 publication Critical patent/EA018931B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/502Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Abstract

В настоящем изобретении предложены новые 1,4-дизамещенные фталазины-антагонисты сигнального пути hedgehog, подходящие для лечения рака.
EA201170640A 2008-11-03 2009-10-22 ДИЗАМЕЩЕННЫЕ ФТАЛАЗИНЫ-АНТАГОНИСТЫ СИГНАЛЬНОГО ПУТИ Hedgehog EA018931B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11070308P 2008-11-03 2008-11-03
PCT/US2009/061573 WO2010062507A1 (en) 2008-11-03 2009-10-22 Disubstituted phthalazine hedgehog pathway antagonists

Publications (2)

Publication Number Publication Date
EA201170640A1 true EA201170640A1 (ru) 2011-12-30
EA018931B1 EA018931B1 (ru) 2013-11-29

Family

ID=41566219

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201170640A EA018931B1 (ru) 2008-11-03 2009-10-22 ДИЗАМЕЩЕННЫЕ ФТАЛАЗИНЫ-АНТАГОНИСТЫ СИГНАЛЬНОГО ПУТИ Hedgehog

Country Status (30)

Country Link
US (1) US8404687B2 (ru)
EP (1) EP2364185B1 (ru)
JP (1) JP2012507535A (ru)
KR (1) KR101335746B1 (ru)
CN (1) CN102202737B (ru)
AU (1) AU2009320251C1 (ru)
BR (1) BRPI0921437A2 (ru)
CA (1) CA2742539C (ru)
CL (1) CL2011000979A1 (ru)
CO (1) CO6382123A2 (ru)
CR (1) CR20110202A (ru)
CY (1) CY1114023T1 (ru)
DK (1) DK2364185T3 (ru)
EA (1) EA018931B1 (ru)
EC (1) ECSP11011021A (ru)
ES (1) ES2418479T3 (ru)
HK (1) HK1159010A1 (ru)
HR (1) HRP20130527T1 (ru)
IL (1) IL211841A0 (ru)
MA (1) MA32726B1 (ru)
MX (1) MX2011004683A (ru)
NZ (1) NZ591945A (ru)
PE (1) PE20110433A1 (ru)
PL (1) PL2364185T3 (ru)
PT (1) PT2364185E (ru)
SI (1) SI2364185T1 (ru)
TN (1) TN2011000166A1 (ru)
UA (1) UA102115C2 (ru)
WO (1) WO2010062507A1 (ru)
ZA (1) ZA201102448B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY156814A (en) * 2007-03-15 2016-03-31 Novartis Ag Organic compounds and their uses
AU2009241561B2 (en) 2008-04-29 2013-05-16 Eli Lilly And Company Disubstituted phthalazine hedgehog pathway antagonists
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
KR101342184B1 (ko) 2008-11-17 2013-12-19 일라이 릴리 앤드 캄파니 사치환된 피리다진 헷지호그 경로 길항제
CA2743264C (en) 2008-11-17 2014-02-18 Julia Marie Clay Tetrasubstituted pyridazines hedgehog pathway antagonists
AR077014A1 (es) 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
US9814703B2 (en) 2013-11-14 2017-11-14 The Board Of Trustees Of The Leland Stanford Junior University Methods for treating cancer by activation of BMP signaling
CN105985320B (zh) * 2015-02-11 2018-10-26 复旦大学 苄基酞嗪化合物及其制备方法和用途
CN105985319B (zh) * 2015-02-11 2019-02-26 复旦大学 芳基酞嗪化合物及其制备方法和用途
CN105985321B (zh) * 2015-02-11 2018-10-26 复旦大学 吡唑酞嗪化合物及其制备方法和用途
US20240124451A1 (en) * 2022-09-23 2024-04-18 Merck Sharp & Dohme Llc Phthalazine derivatives useful as inhibitors of nod-like receptor protein 3

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1293565A (en) 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
DK0876366T3 (da) 1996-01-15 2001-11-05 Janssen Pharmaceutica Nv Angiogenese-inhiberende pyridazinaminer
JP4073961B2 (ja) * 1996-10-01 2008-04-09 協和醗酵工業株式会社 含窒素複素環化合物
JP5067986B2 (ja) 1998-04-09 2012-11-07 ジョンズ ホプキンズ ユニヴァーシティー スクール オブ メディシン ヘッジホッグシグナリング経路の阻害剤としてのステロイドアルカロイド誘導体の使用
US6432970B2 (en) 1998-04-09 2002-08-13 Johns Hopkins University School Of Medicine Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
WO2000074706A1 (en) 1999-06-08 2000-12-14 Lorantis Limited Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
WO2003088970A2 (en) 2002-04-22 2003-10-30 Johns Hopkins University School Of Medicine Modulators of hedgehog signaling pathways, compositions and uses related thereto
WO2004020599A2 (en) 2002-08-29 2004-03-11 Curis, Inc. Hedgehog antagonists, methods and uses related thereto
US8067608B2 (en) * 2003-09-29 2011-11-29 The Johns Hopkins University Hedgehog pathway antagonists
TW200533356A (en) 2004-02-24 2005-10-16 Mitsubishi Pharma Corp Fused pyridazine derivatives
US8338591B2 (en) 2004-05-08 2012-12-25 Novartis International Pharmaceutical Ltd. 3-aryl-5,6-disubstituted pyridazines
UA96565C2 (ru) 2004-09-02 2011-11-25 Дженентек, Инк. Пиридильные ингибиторы хеджхоговской передачи сигнала
EP1900731A1 (de) 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren
MY156814A (en) * 2007-03-15 2016-03-31 Novartis Ag Organic compounds and their uses
AU2008269128B2 (en) 2007-06-25 2012-08-02 Amgen Inc. Phthalazine compounds, compositions and methods of use
EP2188283B1 (en) 2007-09-07 2012-08-15 Amgen Inc. Annelated pyridazines for the treatment of tumors driven by inappropriate hedgehog signalling
AU2009241561B2 (en) 2008-04-29 2013-05-16 Eli Lilly And Company Disubstituted phthalazine hedgehog pathway antagonists
US20100041663A1 (en) 2008-07-18 2010-02-18 Novartis Ag Organic Compounds as Smo Inhibitors
KR101342184B1 (ko) 2008-11-17 2013-12-19 일라이 릴리 앤드 캄파니 사치환된 피리다진 헷지호그 경로 길항제
CA2743264C (en) 2008-11-17 2014-02-18 Julia Marie Clay Tetrasubstituted pyridazines hedgehog pathway antagonists
AR077014A1 (es) 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer

Also Published As

Publication number Publication date
CL2011000979A1 (es) 2011-10-07
ECSP11011021A (es) 2011-06-30
PE20110433A1 (es) 2011-07-09
PL2364185T3 (pl) 2013-10-31
CA2742539A1 (en) 2010-06-03
KR20110066212A (ko) 2011-06-16
US20110190304A1 (en) 2011-08-04
CN102202737A (zh) 2011-09-28
AU2009320251A1 (en) 2010-06-03
CA2742539C (en) 2014-05-06
DK2364185T3 (da) 2013-06-03
JP2012507535A (ja) 2012-03-29
MA32726B1 (fr) 2011-10-02
CY1114023T1 (el) 2016-07-27
EP2364185A1 (en) 2011-09-14
TN2011000166A1 (en) 2012-12-17
HRP20130527T1 (en) 2013-07-31
CR20110202A (es) 2011-06-09
CO6382123A2 (es) 2012-02-15
BRPI0921437A2 (pt) 2018-10-30
ES2418479T3 (es) 2013-08-14
HK1159010A1 (en) 2012-07-27
EP2364185B1 (en) 2013-05-22
AU2009320251B2 (en) 2013-01-24
PT2364185E (pt) 2013-07-24
CN102202737B (zh) 2014-03-26
AU2009320251C1 (en) 2013-08-15
MX2011004683A (es) 2011-06-20
UA102115C2 (ru) 2013-06-10
WO2010062507A1 (en) 2010-06-03
SI2364185T1 (sl) 2013-07-31
ZA201102448B (en) 2012-09-26
EA018931B1 (ru) 2013-11-29
KR101335746B1 (ko) 2013-12-12
IL211841A0 (en) 2011-06-30
NZ591945A (en) 2012-10-26
US8404687B2 (en) 2013-03-26

Similar Documents

Publication Publication Date Title
EA201170640A1 (ru) Дизамещенные фталазины-антагонисты сигнального пути hedgehog
EA201270049A1 (ru) Дизамещенные фталазиновые антагонисты пути hedgehog
CY1122330T1 (el) Συνθεσεις δισκιων μηλεϊνικης νερατινιμπης
EA201171367A1 (ru) Винилиндазолильные соединения
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
CR20140229A (es) Nuevos derivados bicíclicos de dihidroisoquinolin-1-ona
NO20083492L (no) 11-Beta HSD1 inhibitorer
EA201170699A1 (ru) Тетразамещенные пиридазины в качестве антагонистов пути hedgehog
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
MA32938B1 (fr) Composes organiques
EA201071248A1 (ru) Дизамещенные фталазиновые антагонисты пути hedgehog
EA201171063A1 (ru) Фармацевтические составы олмесартана
CL2008003159A1 (es) Compuestos derivados de diaminas sustituidas, sus sales farmaceuticamente aceptables o sus solvatos; compuestos intermediarios; utiles como agentes antiobesidad, mediados por la inhibicion del receptor npy y5.
CR10955A (es) Nuevo procedimiento de sintesis de la agomelatina
BRPI0814772A2 (pt) Indazóis substituídos por 5-piridinona
CR10960A (es) Nuevo procedimiento de sintesis de la agomelatina
UA107671C2 (en) N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
EA201170700A1 (ru) Тетразамещенные пиридазины в качестве антагонистов пути hedgehog
EA201170585A1 (ru) Производные изохинолинона в качестве антагонистов nk3
CR10934A (es) Nuevo procedimiento de sintesis de la agomelatina
EA200971067A1 (ru) Триазолиламинопиримидиновые соединения
MA33932B1 (fr) Dérivés de 2-aldoximino-5-fluoropyrimidine
CL2008001377A1 (es) Proceso para la preparacion de compuestos derivados de tetrahidroquinolinilo.
UA27723U (en) 7-? -hydroxy- ? -(2',4'-dichlorophenoxy)-propyl-8-n-(n'-?-hydroxyethyl)-piperazino-3- methylxanthine revealing hypocholesteremic action
TN2010000489A1 (en) Disubstituted phthalazine hedgehog pathway antagonists

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU